Objective-To study QT dispersion in left ventricular hypertrophy and chronic heart failure and to determine the relation to ventricular arrhythmias. Setting-Investigational laboratory of a tertiary referral centre. Study design-Patients with left ventricular hypertrophy and normal systolic function (n = 14) and patients with chronic heart failure (n = 18) were matched with controls (n = 17 
structural abnormalities that result in a heterogeneous slowing of ventricular depolarisation. After myocardial infarction, and possibly in dilated cardiomyopathy,5 these structural abnormalities may be reflected as late potentials on the high gain signal averaged electrocardiogram. Heterogeneous repolarisation may also cause ventricular re-entry. The surface electrocardiogram QT interval reflects duration of myocardial action potential, and it has been proposed that differences in the QT interval between leads, termed QT dispersion, may reflect regional variations in duration of ventricular action potential, and as such may be indicators of arrhythmogenicity. 6 We therefore hypothesised that in chronic heart failure and in left ventricular hypertrophy-conditions associated with an increased incidence of ventricular arrhythmias-there might be an increase in the surface lead QT dispersion, and that this might reflect the arrhythmic risk.
Patients and methods Patients with stable heart failure (n = 18), defined as left ventricular dysfunction requiring diuretics for control of symptoms, patients with left ventricular hypertrophy and normal systolic function (n = 14) some of whom were on diuretics but only for control of blood pressure, and control patients (n = 17) who had normal left ventricular dimensions and wall thicknesses were recruited. All patients had QRS complexes of normal duration. Serum electrolytes were all within clinically acceptable limits. Cross sectional and M mode echocardiograms were performed and measurements taken for wall thickness, internal ventricular dimensions at both end diastole (LVIDd) and at end systole (LVIDs), and the index of fractional shortening was derived as (LVIDs/LVIDd). Fractional shortening was used as a measure of the severity of mechanical impairment. Groups were matched for age, weight, and cardiac surgical intervention, except that the hypertrophy group had had less coronary surgery (table 1) .
Twelve of the 18 patients with heart failure and 11 of the 17 controls had ischaemic heart disease. Those with heart failure had all had anterior myocardial infarctions. The controls who had ischaemic heart disease as detected by ultrasound had normal left ventricular systolic function and no regional wall motion abnormalities. The hypertrophy group (n = 14) was either hypertensive (n = 6) or had had valve replacement (n-; 5) and the rest had idiopathic hypertrophy (n 3), although This may result in an important systematic error in the determination of QT dispersion if either the minimum or maximum were affected. Thus we removed the extreme maximum and minimum points to obtain a 10 lead set of data and from this determined QT 10 lead range-that is, the difference between the minimum and the maximum values of QT interval from the 10 lead data set. Maximum and minimum values do not include data on the first 10 and 8 points respectively in each set of data, and it may be that early data points are important. We thus included more of these points by taking the SD of the 12 and 10 lead sets of data, the QT 12 lead SD, and QT 10 lead SD. The data were then reanalysed after a rate correction had been applied to the QT interval by the use of the formula QTc = QT/4 RR interval, thus obtaining QTc 12 lead range etc. Finally to correct for intrinsic differences in the QT interval between controls and the other groups the QT 12 lead range was divided into the QT obtained from lead II.
We further examined the possible bias from end point measurement by determining the interval between the maximum and next maximum point and the interval between the minimum and the next point. If there was no significant difference in the different groups between the maximum or minimum point and the next maximum or minimum point it would be unlikely that within group systematic error had occurred at the extremes of QT measurement. This was indeed the case, with the mean distance between the minimum and next point being 14(2) ms and between the maximum and next point being 22(5), with no significant between group difference.
We also considered the distribution of QT analysis of variance (ANOVA) was used and for direct between variable comparison simple linear regression tests were used. For direct comparison between two groups unpaired t tests were used. Significance was at the 5% level.
Results Table 1 shows patient details. Patients with heart failure received more diuretics, had larger hearts at both end diastole and at end systole, depressed baroreflex sensitivity, and higher noradrenaline concentrations than controls. Both hypertrophy and heart failure groups had more ventricular.-crasystoles than controls.
The different QT dispersion measures were related to one another with the 12 and 10 lead QT data being well related to their respective SDs with an r 0 97 and p < 0-0001: thus analysis of the SD provided no extra information than did the range data. The 12 lead data were less well related to the 10 lead data with r = 0-58 and p < 0000 1. The QT lead II range data were effectively the same as the 12 lead data with r = 0-98 and p < 0 0001. The different measures of QT dispersion all produced the same qualitative results. The mean distance between the minimum and next point was 14(2) ms and between the maxmum and next point was 22(5), with no significant between group difference, thus suggesting that end point bias had not occurred.
All measures of QT dispersion were increased (table 3) in left ventricular hypertrophy compared with controls. There was a tendency for QT dispersion to be increased in heart failure, although this did not reach significance. Not surprisingly, once Bazett's correction was applied the mean dispersion increased in the heart failure group due to a higher mean heart rate, though the comparison with the control group still did not reach significance. When disease classification and position from the mean QT interval were tested against time from the mean QT interval in a two-factor ANOVA, disease classification significantly affected time from the mean QT interval (p < 0-001). When patients with hypertrophy or heart failure were separately tested against the control both hypertrophy (p < 0-0001) and heart failure (p < 0 02) were still separately significant determi- nants of time from the mean QT interval. Thus QT intervals around the mean was influenced by left ventricular disease (fig 1) . Presence of ischaemic heart disease non-significantly increased measures of QT distribution in both controls and patients with heart failure. Figure 1 shows the cumulative plot of the difference between QT duration and its mean: though this suggests that the increase in QT dispersion in patients with hypertrophy occurs throughout the range, further analysis showed that this was not the case. The time from the mean that contained 50% of the data points was not significantly different between the groups (12.9(1-2) ms in controls, 16-6(2-1) ms in hypertrophy, and 14A4(1-4) ms in heart failure). Thus the first six QT intervals from each patient's electrocardiogram show an identical pattern spread around the mean QT interval. The separation between the hypertrophy group and the others only reaches significance on the eighth point, and remains significant through to the 12th point (fig 2) .
The autonomic and mechanical factors associated with QT dispersion were then examined. Fractional shortening, an index of resting cardiac mechanical function, was not related by linear regression analysis to any of the indices of QT dispersion, although left ventricular end diastolic dimension was related to the 10 lead SD with r = 0-38 and p < 0-05. There was no relation between end 75_I e n Control (fig 3) .
The relation of QT dispersion to abnormalities on the Holter monitoring was With simple linear regression analysis there was no relation between any measure of QT dispersion and extrasystole frequency. When extrasystole frequency was dichotomised at 120 extrasystoles/24 h (the midpoint of the CAST extrasystolic frequency to mortality dose-response curve) the controls separated from the hypertrophy and heart failure groups (p < 0-001) and when dichotomised at 480 extrasystoles/24 h the heart failure group separated from the other two groups (p < 0-005). As the 480 extrasystoles/24 h data produced qualitatively similar results to the data of 120 extrasystoles/24 h only the 120 extrasystoles/24 h data are presented. The relation of the dichotomised extrasystolic frequency to mechanical impairment, autonomic abnormalities, and the different measures of QT dispersion was studied (table   3) . The groups successfully dichotomised on the basis of left ventricular dimensions and baroreflex sensitivity. There were, however, no significant differences in any of the measures of QT dispersion at either of the two levels. There was a trend at the 120 extrasys-'-toles/24 h level for those with the higher extrasystolic frequency to have greater QT dispersion, although this was not significant.
The relation between the presence of nonsustained ventricular tachycardia (n = 4) and our measures of QT dispersion was studied. Patients with ventricular tachycardia had significantly larger end diastolic volumes, but did not differ significantly in any measure of QT dispersion.
Discussion
These data show that QT dispersion is increased in patients with left ventricular hypertrophy, and tends to increase in patients with chronic heart failure. The overall distribution of QT intervals around the mean is altered significantly in patients with left ventricular hypertrophy or heart failure. The QT dispersion has been reported to be increased after myocardial infarction8 and unchanged in heart failure without sustained tachycardias. 
The QT interval reflects the duration of the action potential of the ventricular myocytes" and interventions-such as, amiodarone-that alter durations of cellular action potentials also similarly alter the QT interval. Whether QT dispersion accurately reflects regional abnormalities is not yet established. Studies comparing duration of the epicardial action potential with surface lead QT dispersion support this concept'2 as does the finding that QT dispersion increases in the hereditary long QT syndrome.61213 Our finding of increased QT dispersion in patients with left ventricular hypertrophy may reflect the increased range of duration of ventricular action potentials'4 and activation times.'5 A relation between QT dispersion and arrhythmias is not supported by our data. We found no relation between QT dispersion and frequency of extrasystoles, ventricular tachycardia, or the degree of mechanical impairment (an arrhythmic risk factor),'6 and at best we found a weak relation between QT dispersion and baroreflex sensitivity (an indicator for future arrhythmic events). Furthermore our finding of a greater QT dispersion in left ventricular hypertrophy than in heart failure, given that the incidence of arrhythmic deaths is higher in chronic heart failure'8 19 The aetiology of the increase in QT dispersion is not clear. The finding of increased QRS duration in those with greater QT dispersion suggests that clinically minor degrees of conducting tissue disease, as is commonly found either in hypertrophy (delayed intrinsicoid deflection) or ischaemic heart disease, might have important consequences for the uniformity of repolarisation. The small increase in the QRS duration (7 ms) would by itself only produce a small increase in QT dispersion: it is therefore likely that the increase in QRS duration is an indicator of the underlying disease process rather than the cause of the increase in QT dispersion. The greater increase in QT dispersion in hypertrophy than in heart failure may be a reflection of changes in basic cellular electrophysiology, some of which (in guinea pig models)2829 are greater in hypertrophy than in heart failure.
It is possible that the increase in QT dispersion is an artefact caused by the difficulty of reading electrocardiograms from diseased hearts. In part we have minimised this by multiple readings of each QT interval. About 3000 digitised QT values were obtained. This technique minimises random but not systematic reading errors: these may occur in heart failure due to flat T waves (underestimate) or in left ventricular hypertrophy due to prominent U waves (overestimate). These reading difficulties are unlikely to affect more than a few leads: thus it was reassuring to see that the 10 lead data produced results that were empirically identical to the 12 lead data, suggesting that this finding was not an artefact. The QT distribution around the mean plot, with deviations consistently greater than the control early on, reaching significance by the eighth data point, also strongly suggest that these findings are not due to spurious end point bias, but represent a more generalised abnormality in QT distribution.
In summary, these data suggest that there is a significant increase in the QT dispersion between leads in left ventricular hypertrophy and a non-significant tendency to increase in chronic heart failure. The QT dispersion did not correlate with indices of mechanical impairment or autonomic function. Also, there seemed to be no connection between increases in QT dispersion and arrhythmia as measured on 24 hour Holter monitoring. 
